Bernd Dörken
1985–2018 年に発表
- 140
- 論文数
- 27,531
- 被引用数
- 100
- h 指数
- 140
- i10 指数
被引用数
引用元
国・地域
機関
分野
- Medicine58.7%
- Biochemistry, Genetics and Molecular Biology29.6%
- Immunology and Microbiology6.7%
- Materials Science1.4%
- Agricultural and Biological Sciences1.2%
- Engineering0.6%
- その他1.8%
トピック
- Lymphoma Diagnosis and Treatment5.1%
- Telomeres, Telomerase, and Senescence3.3%
- Immune Cell Function and Interaction2.3%
- CAR-T cell therapy research2.2%
- Cell death mechanisms and regulation2.2%
- Chronic Lymphocytic Leukemia Research2.2%
- その他82.7%
共著者
- Ioannis Anagnostopoulos20
- Stephan Mathas20
- Harald Stein19
- Peter T. Daniel18
- Kurt Bommert17
- Franziska Jundt16
- Hanno Riess15
- Michael Hummel15
- Martin Janz14
- Georg Lenz13
- Ralf C. Bargou13
- Claus Scheidereit12
- Clemens A. Schmitt11
- Michael Grau10
- Peter Lenz10
- Uwe Pelzer10
- Helmut Oettle9
- Jens Stieler9
- Daniel Krappmann8
- Korinna Jöhrens8
- Markus Y. Mapara8
- Peter Reichardt8
- Thomas Wieder8
- Andreas Engert7
全論文
- Senescence-associated reprogramming promotes cancer stemness
著者: Maja Milanovic, Dorothy Ngo-Yin Fan, Dimitri Belenki, J. Henry M. Däbritz, Zhen Zhao, Yong Yu, Jan R. Dörr, Lora Dimitrova, Dido Lenze, Inês Amorim Monteiro Barbosa, Marco Antonio Mendoza-Parra, Tamara Kanashova, Marlen Metzner, Katharina Pardon, Maurice Reimann, Andreas Trumpp, Bernd Dörken, Johannes Zuber, Hinrich Gronemeyer, Michael Hummel, Gunnar Dittmar, Soyoung Lee, Clemens A. Schmitt - Nature 2017 被引用: 1,146
- Synthetic lethal metabolic targeting of cellular senescence in cancer therapy
著者: Jan R. Dörr, Yong Yu, Maja Milanovic, Gregor Beuster, Christin Zasada, J. Henry M. Däbritz, Jan Lisec, Dido Lenze, Anne Gerhardt, Katharina Schleicher, Susanne Kratzat, Bettina Purfürst, Stefan Walenta, Wolfgang Mueller‐Klieser, Markus H. Gräler, Michael Hummel, Ulrich Keller, Andreas K. Buck, Bernd Dörken, Lothar Willmitzer, Maurice Reimann, Stefan Kempa, Soyoung Lee, Clemens A. Schmitt - Nature 2013 被引用: 539
- Oncogene-induced senescence as an initial barrier in lymphoma development
著者: Melanie Braig, Soyoung Lee, Christoph Loddenkemper, Cornelia Rudolph, Antoine H.F.M. Peters, Brigitte Schlegelberger, Harald Stein, Bernd Dörken, Thomas Jenuwein, Clemens A. Schmitt - Nature 2005 被引用: 1,206
- CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial
著者: Marianne Sinn, Marcus Bahra, Torsten Liersch, Klaus Gellert, Helmut Messmann, Wolf O. Bechstein, Dirk Waldschmidt, Lutz Jacobasch, Martin Wilhelm, Bettina Rau, Robert Grützmann, Arndt Weinmann, Georg Maschmeyer, Uwe Pelzer, Jens Stieler, Jana K. Striefler, Michael Ghadimi, Sven Bischoff, Bernd Dörken, Helmut Oettle, Hanno Riess - Journal of Clinical Oncology 2017 被引用: 296
- A recombinant bispecific single-chain antibody, CD19 × CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes
著者: Anja Löffler, Peter Kufer, Ralf Lutterbüse, Florian Zettl, Peter T. Daniel, Jan M. Schwenkenbecher, Gert Riethmüller, Bernd Dörken, Ralf C. Bargou - Blood 2000 被引用: 445
- Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis
著者: Christopher Maximilian Arends, Joel Galan-Sousa, Kaja Hoyer, Willy Chan, Marten Jäger, Kenichi Yoshida, Ricarda Seemann, Daniel Noerenberg, Nils Waldhueter, Helga Fleischer-Notter, Friederike Christen, Clemens A. Schmitt, Bernd Dörken, Uwe Pelzer, Marianne Sinn, Tomasz Żemojtel, Seishi Ogawa, Sven Märdian, Adrian Schreiber, Annegret Kunitz, Ulrike Krüger, Lars Bullinger, Elena Mylonas, Mareike Frick, Frédérik Damm - Leukemia 2018 被引用: 191
- Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma
著者: Björn Lamprecht, Korden Walter, Stephan Kreher, Raman Kumar, Michael Hummel, Dido Lenze, Karl Köchert, Mohamed Amine Bouhlel, Julia Richter, Éric Soler, Ralph Stadhouders, Korinna Jöhrens, Kathrin D. Wurster, David F. Callen, Michael F. Harte, Maciej Giefing, Rachael Barlow, Harald Stein, Ioannis Anagnostopoulos, Martin Janz, Peter N. Cockerill, Reiner Siebert, Bernd Dörken, Constanze Bonifer, Stephan Mathas - Nature Medicine 2010 被引用: 375
- Second-Line Oxaliplatin, Folinic Acid, and Fluorouracil Versus Folinic Acid and Fluorouracil Alone for Gemcitabine-Refractory Pancreatic Cancer: Outcomes From the CONKO-003 Trial
著者: Helmut Oettle, Hanno Riess, Jens Stieler, Gerhard Heil, Ingo Schwaner, Jörg Seraphin, Martin Görner, Matthias Mölle, Tim F. Greten, Volker Lakner, Sven Bischoff, Marianne Sinn, Bernd Dörken, Uwe Pelzer - Journal of Clinical Oncology 2014 被引用: 484
- Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma
著者: Yong Yu, Kolja Schleich, Bin Yue, Sujuan Ji, Philipp Lohneis, Kristel Kemper, Mark R. Silvis, Nouar Qutob, Ellen van Rooijen, Melanie Werner‐Klein, Lianjie Li, Dhriti Dhawan, Svenja Meierjohann, Maurice Reimann, Abdel Elkahloun, Steffi Treitschke, Bernd Dörken, Christian Speck, Frédérick A. Mallette, Leonard I. Zon, Sheri L. Holmen, Daniel S. Peeper, Yardena Samuels, Clemens A. Schmitt, Soyoung Lee - Cancer Cell 2018 被引用: 159
- Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma
著者: Rami Rahal, Mareike Frick, Rodrigo Romero, Joshua M. Korn, Robert Kridel, Fong Chun Chan, Barbara Meissner, Hyo-Eun Carrie Bhang, Dave Ruddy, Audrey Kauffmann, Ali Farsidjani, Adnan Derti, Daniel P. Rakiec, Tara L. Naylor, Estelle Pfister, Steve G. Kovats, Sunkyu Kim, Kerstin Dietze, Bernd Dörken, Christian Steidl, Alexandar Tzankov, Michael Hummel, John E. Monahan, Michael Morrissey, Christine Fritsch, William R. Sellers, Vesselina G. Cooke, Randy D. Gascoyne, Georg Lenz, Frank Stegmeier - Nature Medicine 2013 被引用: 332
- Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma
著者: Andreas Engert, Annette Plütschow, Hans Theodor Eich, Andreas Lohri, Bernd Dörken, Peter Borchmann, Bernhard Berger, Richard Greil, Kay Willborn, Martin Wilhelm, Jürgen Debus, Michael J. Eble, Martin Sökler, Antony D. Ho, Andreas Rank, Arnold Ganser, Lorenz Trümper, Carsten Bokemeyer, Hartmut Kirchner, Jörg Schubert, Zdeněk Král, Michael Fuchs, Hans–Konrad Müller–Hermelink, Rolf‐Peter Müller, Volker Diehl - New England Journal of Medicine 2010 被引用: 921
- Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypes
著者: Matthias Pfeifer, Bing Zheng, Tabea Erdmann, Hartmut Koeppen, Ronald McCord, Michael Grau, Annette M. Staiger, Akiko Chai, Thomas Sandmann, Hannelore Madle, Bernd Dörken, Y-W Chu, A I Chen, Dan I. Lebovic, Gilles Salles, M. S. Czuczman, Maria Corinna Palanca-Wessels, Oliver W. Press, Ranjana H. Advani, Franck Morschhauser, Bruce D. Cheson, Peter Lenz, German Ott, Andrew G. Polson, Kirsten Mundt, Georg Lenz - Leukemia 2015 被引用: 152
- Tumor Stroma-Derived TGF-β Limits Myc-Driven Lymphomagenesis via Suv39h1-Dependent Senescence
著者: Maurice Reimann, Soyoung Lee, Christoph Loddenkemper, Jan R. Dörr, Vedrana Tabor, Peter Aichele, Harald Stein, Bernd Dörken, Thomas Jenuwein, Clemens A. Schmitt - Cancer Cell 2010 被引用: 179
- Efficacy of Prophylactic Low–Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial
著者: Uwe Pelzer, Bernhard Opitz, G. Deutschinoff, Martina Stauch, P Reitzig, S. Hahnfeld, Lothar Müller, Martina Grunewald, Jens Stieler, Marianne Sinn, Timm Denecke, Sven Bischoff, Helmut Oettle, Bernd Dörken, Hanno Riess - Journal of Clinical Oncology 2015 被引用: 266
- Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial
著者: Andreas Engert, Heinz Haverkamp, Carsten Kobe, Jana Marková, Christoph Renner, Antony D. Ho, Josée M. Zijlstra, Zdeněk Král, Michael Fuchs, Michael Hallek, Lothar Kanz, Hartmut Döhner, Bernd Dörken, Nicole Engel, Max S. Topp, Susanne Klutmann, Holger Amthauer, Andreas Bockisch, Regine Kluge, Clemens Kratochwil, Otmar Schober, Richard Greil, Reinhard Andreesen, Michael Kneba, Michael Pfreundschuh, Harald Stein, Hans Theodor Eich, Rolf‐Peter Müller, Markus Dietlein, Peter Borchmann, Volker Diehl - The Lancet 2012 被引用: 632
- Pharmacologic Inhibition of MALT1 Protease by Phenothiazines as a Therapeutic Approach for the Treatment of Aggressive ABC-DLBCL
著者: Daniel Nagel, Stefani Spranger, Michelle Vincendeau, Michael Grau, Silke Raffegerst, Bernhard Kloo, Daniela Hlahla, Martin Neuenschwander, Jens Peter von Kries, Kamyar Hadian, Bernd Dörken, Peter Lenz, Georg Lenz, Dolores J. Schendel, Daniel Krappmann - Cancer Cell 2012 被引用: 229
- Cellular senescence predicts treatment outcome in metastasised colorectal cancer
著者: Anja Haugstetter, Christoph Loddenkemper, Dido Lenze, Jörn Gröne, Christoph Standfuß, Iver Petersen, Bernd Dörken, Clemens A. Schmitt - British Journal of Cancer 2010 被引用: 121
- The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma
著者: Nikolai Schleußner, Olaf Merkel, Mariantonia Costanza, Huan-Chang Liang, Franziska Hummel, Chiara Romagnani, Pawel Durek, Ioannis Anagnostopoulos, Michael Hummel, Korinna Jöhrens, Antonia Niedobitek, Patrick R. Griffin, Roberto Piva, Henrike L. Sczakiel, Wilhelm Woessmann, Christine Damm‐Welk, Christian Hinze, Dagmar Stoiber, Bernhard Gillissen, Suzanne D. Turner, Eva Kaergel, Linda von Hoff, Michael Grau, Georg Lenz, Bernd Dörken, Claus Scheidereit, Lukas Kenner, Martin Janz, Stephan Mathas - Leukemia 2018 被引用: 89
- Aberrantly expressed c‐Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF‐κB
著者: Stephan Mathas, Michael Hinz, Ioannis Anagnostopoulos, Daniel Krappmann, Andreas Lietz, Franziska Jundt, Kurt Bommert, Fatima Mechta‐Grigoriou, Harald Stein, Bernd Dörken, Claus Scheidereit - The EMBO Journal 2002 被引用: 377
- Macrophage inflammatory protein 1-alpha (MIP-1α) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells
著者: Suzanne Lentzsch, Margarete Gries, Martin Janz, Ralf C. Bargou, Bernd Dörken, Markus Y. Mapara - Blood 2003 被引用: 218
- Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: A phase III-study from the German CONKO-study group
著者: Uwe Pelzer, Ingo Schwaner, Jens Stieler, Mathias Adler, Jörg Seraphin, Bernd Dörken, Hanno Riess, Helmut Oettle - European Journal of Cancer 2011 被引用: 380
- PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma
著者: Matthias Pfeifer, Michael Grau, Dido Lenze, Sören-Sebastian Wenzel, Annette Wolf, Brigitte Wollert‐Wulf, Kerstin Dietze, Hendrik Nogai, Benjamin Storek, Hannelore Madle, Bernd Dörken, Martin Janz, Stephan Dirnhofer, Peter Lenz, Michael Hummel, Alexandar Tzankov, Georg Lenz - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 被引用: 262
- Malt1-dependent RelB cleavage promotes canonical NF-κB activation in lymphocytes and lymphoma cell lines
著者: Stephan Hailfinger, Hendrik Nogai, Christiane Pelzer, Maike Jaworski, Katrin Cabalzar, Jean-Enno Charton, Montserrat Guzzardi, Chantal Décaillet, Michael Grau, Bernd Dörken, Peter Lenz, Georg Lenz, Margot Thome - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 被引用: 236
- IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL
著者: Hendrik Nogai, Sören-Sebastian Wenzel, Stephan Hailfinger, Michael Grau, Eva Kaergel, Volkhard Seitz, Brigitte Wollert‐Wulf, Matthias Pfeifer, Annette Wolf, Mareike Frick, Kerstin Dietze, Hannelore Madle, Alexandar Tzankov, Michael Hummel, Bernd Dörken, Claus Scheidereit, Martin Janz, Peter Lenz, Margot Thome, Georg Lenz - Blood 2013 被引用: 88
